Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial

BACKGROUND: Treatment options for patients with advanced hepatocellular carcinoma (HCC) are often limited. In most cases, they are not amenable to local therapies including surgery or radiofrequency ablation. The multi-kinase inhibitor sorafenib has shown to increase overall survival in this patient...

Full description

Saved in:
Bibliographic Details
Main Authors: Combs, Stephanie E, Habermehl, Daniel, Ganten, Tom, Schmidt, Jan, Edler, Lutz, Burkholder, Iris, Jäkel, Oliver, Haberer, Thomas, Debus, Jürgen
Format: Artigo
Language:Inglês
Published: BioMed Central 2011
Subjects:
Study Protocol
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3045987/
https://ncbi.nlm.nih.gov/pubmed/21314962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-67
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items